Effectiveness of zonisamide in a patient with Parkinson's disease and various levodopa-induced psychotic symptoms

被引：3
|
作者：
Yabe, Ichiro [1 ]
Ohta, Midori [2 ]
Egashira, Toshiaki [3 ]
Sato, Kazunori [1 ]
Kano, Takahiro [1 ]
Hirotani, Makoto [1 ]
Kunieda, Yasuyuki [4 ]
Sasaki, Hidenao [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan
[2] Wakkanai City Hosp, Rehabil Ctr, Wakkanai, Hokkaido, Japan
[3] Wakkanai City Hosp, Dept Psychiat, Wakkanai, Hokkaido, Japan
[4] Wakkanai City Hosp, Dept Internal Med, Wakkanai, Hokkaido, Japan
来源：
NEUROLOGY AND CLINICAL NEUROSCIENCE | 2014年 / 2卷 / 06期
关键词：
dopamine agonists; levodopa; Parkinson's disease; psychotic symptoms; zonisamide;
D O I：
10.1111/ncn3.126
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Levodopa and dopamine agonists are useful as Parkinson's disease medications. However, they often induce persistent psychotic symptoms and motor complications, which make Parkinson's disease treatment difficult. This is a case report of a patient with advanced Parkinson's disease accompanied by exacerbation of motor symptoms and psychotic symptoms derived from prolonged use of conventional anti-Parkinson's disease drugs, and in whom adjunctive therapy with a new anti Parkinson's disease drug, zonisamide, was shown to improve motor symptoms with no exacerbation of psychotic symptoms.
引用
收藏
页码：201 / 203
页数：3
相关论文
共 50 条
  • [21] Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease
    Rice, JE
    Antic, R
    Thompson, PD
    MOVEMENT DISORDERS, 2002, 17 (03) : 524 - 527
  • [22] Levodopa-induced changes in neurovascular reactivity in Parkinson's disease
    Jourdain, V. A.
    Holtbernd, F.
    Tang, C. C.
    Dhawan, V.
    Eidelberg, D.
    MOVEMENT DISORDERS, 2015, 30 : S11 - S11
  • [23] Risk factors for levodopa-induced dyskinesias in Parkinson’s disease
    F. Grandas
    Maria Luisa Galiano
    Cesar Tabernero
    Journal of Neurology, 1999, 246 : 1127 - 1133
  • [24] Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia
    Yoo, Han Soo
    Choi, Yong Ho
    Chung, Seok Jong
    Lee, Yang Hyun
    Ye, Byoung Seok
    Sohn, Young H.
    Lee, Jong-Min
    Lee, Phil Hyu
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (11): : 2251 - 2260
  • [25] Future scenarios for levodopa-induced dyskinesias in Parkinson's disease
    Cerasa, Antonio
    Koch, Giacomo
    Fasano, Alfonso
    Morgante, Francesca
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [26] Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease
    Cheshire, Perdita A.
    Williams, David R.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (03) : 343 - 348
  • [27] Levodopa-induced dyskinesia and neurocognitive function in Parkinson's disease
    Oggioni, G. D.
    Devoto, J.
    Cantello, R.
    Espay, A. J.
    MOVEMENT DISORDERS, 2012, 27 : S29 - S29
  • [28] Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease
    Metman, LV
    Del Dotto, P
    Natté, R
    van den Munckhof, P
    Chase, TN
    NEUROLOGY, 1998, 51 (01) : 203 - 206
  • [29] Levetiracetam for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
    Stathis, P.
    Konitsiotis, S.
    Tagaris, G.
    Peterson, D.
    MOVEMENT DISORDERS, 2011, 26 (02) : 264 - 270
  • [30] Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease
    Hoff, JI
    vander Plas, AA
    Wagemans, EAH
    van Hilten, JJ
    MOVEMENT DISORDERS, 2001, 16 (01) : 58 - 61
12345